There were 1,519 press releases posted in the last 24 hours and 405,877 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
FibroGen Announces Topline Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image